Recruiting
Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer
NCT07127822
- Conditions
- Gastric / Gastroesophageal Junction Adenocarcinoma, MSI-H Cancer
- Locations
-
- Department of GI Oncology, Peking University Cancer Hospital Beijing, China
- The Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China
- Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China